Search - tctmd.com

Displaying 1 - 20 of 638

Sort: Relevancy | Date

CTO PCI Reduces Symptoms, Improves Quality of Life: Meta-Analysis

News Daily News

CTO PCI Reduces Symptoms, Improves Quality of Life: Meta-Analysis

Michael O'Riordan

April 09, 2026

Despite Guidelines, Aspirin Is Used in Fewer Than One in Four High-risk Pregnancies

News Conference News ACC 2026

Despite Guidelines, Aspirin Is Used in Fewer Than One in Four High-risk Pregnancies

Yael L. Maxwell

April 03, 2026

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

News Conference News ACC 2026

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

Michael O'Riordan

April 01, 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Michael O'Riordan

March 30, 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

News Conference News ACC 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Michael O'Riordan

March 29, 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

News Conference News ACC 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

Yael L. Maxwell

March 28, 2026

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

News Conference News ACC 2026

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

March 28, 2026

March 2026 Dispatch for the CV Team

News Opinion CV Team Dispatch

March 2026 Dispatch for the CV Team

March 26, 2026

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

News Daily News

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

March 25, 2026

What’s Going to Be Hot at ACC 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

News Daily News

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

Yael L. Maxwell

March 19, 2026

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

News Daily News

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Yael L. Maxwell

March 16, 2026

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

News Daily News

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

Michael O'Riordan

March 13, 2026

Side Effects of Statins Might Be Overstated: CTT Collaboration

News Daily News

Side Effects of Statins Might Be Overstated: CTT Collaboration

Michael O'Riordan

February 12, 2026

OPTION: IV Tenecteplase Boosts Outcomes Late After Non-LVO Stroke

News Conference News ISC 2026

OPTION: IV Tenecteplase Boosts Outcomes Late After Non-LVO Stroke

February 11, 2026

OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding

News Conference News ISC 2026

OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding

February 09, 2026

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

News Conference News ISC 2026

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

February 06, 2026

TCTMD’s Top 10 Most Popular Stories for January 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2026

February 02, 2026

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

News Daily News

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

January 29, 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.